Results 241 to 250 of about 29,060 (271)

?????????????????? ?????????????????????????????? ?????????????? ?????????? ??24 ???????????? BLV

2009
?????????????????????? ?????????????????????????????????? ???????????????????? ?????????????????? ?????????????????????????????? ?????????????? ?????????? ??24 ???????????? ???????????? ???????????????? ?? ?????????????????????????????? ?????????????? ?????????????????????????????????? ?????????????? (??????) ?????????????????????? ????????????????????.
openaire   +1 more source

Bundeslaufbahnverordnung – BLV – Auszug

2022
Anke Borsdorff, Martin Kastner, Christian Deyda   +2 more
openaire   +1 more source

Increasing Bovine leukemia virus (BLV) proviral load is a risk factor for progression of Enzootic bovine leucosis: A prospective study in Japan.

Preventive Veterinary Medicine, 2020
Tomoko Kobayashi, Yasuko Inagaki, Nagaki Ohnuki, R. Sato, S. Murakami, K. Imakawa   +5 more
semanticscholar   +1 more source

[Polymerase chain reaction (PCR) for detection of BLV provirus-- a practical complement for BLV diagnosis?].

Berliner und Munchener tierarztliche Wochenschrift, 1998
A typical infection with bovine leukemia virus (BLV) induces a permanent antibody (Ab) response with high titers against BLV-antigens. In the last few years atypical courses of infection with low or transient BLV-Ab-titers or even lack of any detectable BLV-Ab-titers in animals with BLV-provirus integration have been described.
P, Blankenstein, H, Fechner, A C, Looman, D, Beier, O, Marquardt, D, Ebner   +5 more
openaire   +1 more source

The BLV-miRNAs pathway of BLV inhibits the expression of Lactoferrin, Lactoperoxidase, Alpha-lactalbumin and Beta-lactoglobulin proteins

Veterinary Microbiology
Bovine leukemia virus (BLV) is a widespread virus that decreases milk production and quality in dairy cows. As crucial components of BLV, BLV-encoded microRNAs (BLV-miRNAs) affect BLV replication and may impact the synthesis of Lactoferrin (LTF), Lactoperoxidase (LPO), Alpha-lactalbumin (alpha-LA), and Beta-lactoglobulin (beta-LG).
Shuai, Lian, Han, Zhang, Yandi, Wang, Jiahe, Song, Pengfei, Liu, Zijian, Geng, Rui, Wu, Di, Wang, Jianfa, Wang   +8 more
openaire   +2 more sources

Peptide-based bovine leukemia virus (BLV) vaccine that induces BLV-Env specific Th-1 type immunity.

Leukemia, 1997
In controlling retrovirus infection and replication, cell-mediated immunity (CMI) is considered to be effective. To develop a synthetic peptide vaccine capable of inducing CMI, mannan-coated liposome encapsulating 20-mer synthetic peptide, spanning the 98-117 amino acids of bovine leukemia virus (BLV) envelope glycoprotein (Env) gp51 was constructed ...
K, Ohishi, H, Kabeya, H, Amanuma, M, Onuma   +3 more
openaire   +1 more source

Biological activity of native BLV proteinase and C-terminal truncated BLV and HTLV-I proteinases

1994
Human T-cell leukemia virus is a T-cell lymphotropic retrovirus associated with T-cell leukemia and tropical spastic paraparesis, whereas bovine leukemia virus is the etiological agent of enzootic bovine lymphosarcoma. Bovine leukemia virus is reported as the animal model of human T-cell leukemia virus.
Précigoux, Gilles, Llido, Sabine, Léonard, B., Guillemain, A., Ménard, T., Candresse, Thierry, Le Gall, Olivier   +6 more
openaire   +1 more source

MITICA BLV and BSV design

2011
-
Rigato W., Zaccaria P., Muraro D., Mazzucco G.   +3 more
openaire   +1 more source

Development of an in situ hybridization assay using an AS1 probe for detection of bovine leukemia virus in BLV-induced lymphoma tissues

Archives of Virology, 2020
Kiyohiko Andoh, K. Kimura, A. Nishimori, S. Hatama   +3 more
semanticscholar   +1 more source

TRANSACTIVATION ACTIVITY OF THE BLV TAX DERIVED FROM BLV-INFECTED ALEUKEMIC AND LEUKEMIC CATTLE

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 1999
Shigeru Tajima, Yoko Aida
openaire   +1 more source